A Washington, D.C., court has ruled that incurable patients cannot access experimental drugs after phase I clinical trials. The 8-2 ruling by the full U.S. Court of Appeals for the District of Columbia reversed a May 2006 ruling by a divided three-judge appeals panel, which overturned a 2004 district court decision to throw out the case. The AAMC and other organizations filed amicus briefs in the case supporting the U.S. Food and Drug Administration's clinical trials process. For more information, please visit http://pacer.cadc.uscourts.gov/docs/common/opinions/200708/04-5350c.pdf.